Concepedia

Eri Kobayashi

EK

10

Publications

1K

Citations

10

H-Index

1994

Active since

Affiliations

Alexion Pharmaceuticals (United States)(Current)

Nagoya University

International University of Health and Welfare

Stanford University

National Hospital Organization Hanamaki Hospital

Eri Kobayashi is an author at Alexion Pharmaceuticals (United States) specializing in medicine, kinesiology, and human movement.

ORCID

Top concepts

Publications per year

1994–2021

10

Publications

10

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar et al. · The Lancet Neurology · 2017 · 745 citations

, , +3

Characterization of cDNAs Induced in Meiotic Prophase in Lily Microsporocytes

Toshiyuki Kobayashi, Eri Kobayashi, Shusei Sato et al. · DNA Research · 1994 · 98 citations · Full text

Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension

Renato Mantegazza, Gil I. Wolfe, Srikanth Muppidi et al. · Neurology · 2020 · 74 citations · Full text

Long-term efficacy and safety of eculizumab in Japanese patients with generalized myasthenia gravis: A subgroup analysis of the REGAIN open-label extension study

Hiroyuki Murai, Akiyuki Uzawa, Yasushi Suzuki et al. · Journal of the Neurological Sciences · 2019 · 23 citations · Full text

Glycerophospholipid profile alterations are associated with murine muscle‐wasting phenotype

Nanami Senoo, Noriyuki Miyoshi, Eri Kobayashi et al. · Muscle & Nerve · 2020 · 22 citations

Rows per page

1–5 of 10